| Ident. | Authors (with country if any) | Title |
|---|
| 001A63 (2005) |
U. Sundram [États-Unis] ; Y. Natkunam [États-Unis] | Mast Cell Tryptase and Microphthalmia Transcription Factor Effectively Discriminate Between Cutaneous Mast Cell Disorders and Leukemia Cutis: A Comparative Cytochemical and Immunohistochemical Study |
| 001B10 (2005) |
M. A. A. Al-Rawi [Royaume-Uni] ; G. Watkins [Royaume-Uni] ; R. E. Mansel [Royaume-Uni] ; W. G. Jiang [Royaume-Uni] | Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo |
| 001B35 (2005) |
Jordan S. Orange [États-Unis] ; Ofer Levy [États-Unis] ; Raif S. Geha [États-Unis] | Human disease resulting from gene mutations that interfere with appropriate nuclear factor‐κB activation |
| 001B50 (2005) |
Kentaro Kajiya [Suisse, États-Unis] ; Satoshi Hirakawa [États-Unis] ; Beijia Ma [États-Unis] ; Ines Drinnenberg [Suisse] ; Michael Detmar [Suisse, États-Unis] | Hepatocyte growth factor promotes lymphatic vessel formation and function |
| 001B51 (2005) |
N. Manabe ; Y. Goto ; S. Anan ; T. Suzuki [Japon] ; Y. Matsuura [Japon] ; T. Miyamura [Japon] | Hepatitis C Virus Infection is Highly Correlated with Hepatocellular Apoptosis and Transforming Growth Factor‐β1 MRNA Expression in Patients with Chronic Hepatitis C |
| 001C70 (2005) |
Kanako Miyabayashi [Japon] ; Takashi Shimizu [Japon] ; Chiaki Kawauchi [Japon] ; Hiroshi Sasada [Japon] ; Eimei Sato [Japon] | Changes of mRNA expression of vascular endothelial growth factor, angiopoietins and their receptors during the periovulatory period in eCG/hCG‐treated immature female rats |
| 001D86 (2004) |
Marika J. Karkkainen [Finlande] ; Paula Haiko [Finlande] ; Kirsi Sainio [Finlande] ; Juha Partanen [Finlande] ; Jussi Taipale [Finlande] ; Tatiana V. Petrova [Finlande] ; Michael Jeltsch [Finlande] ; David G. Jackson [Royaume-Uni] ; Marja Talikka [Finlande] ; Heikki Rauvala [Finlande] ; Christer Betsholtz [Suède] ; Kari Alitalo [Finlande] | Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins |
| 001E36 (2004) |
Y. Amo [Japon] ; M. Masuzawa [Japon] ; Y. Hamada [Japon] ; K. Katsuoka [Japon] | Serum concentrations of vascular endothelial growth factor‐D in angiosarcoma patients |
| 002109 (2004) |
S. Trompezinski [France] ; O. Berthier-Vergnes [France] ; A. Denis [France] ; D. Schmitt [France] ; J. Viac [France] | Comparative expression of vascular endothelial growth factor family members, VEGF‐B, ‐C and ‐D, by normal human keratinocytes and fibroblasts |
| 002498 (2002) |
Tatsuru Ota [Japon] ; Makiko Fujii [Japon] ; Takashi Sugizaki [Japon] ; Masami Ishii [Japon] ; Keiji Miyazawa [Japon] ; Hiroyuki Aburatani [Japon] ; Kohei Miyazono [Japon] | Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells |
| 002505 (2002) |
Yulong He [Finlande] ; Ken-Ichi Kozaki [Finlande] ; Terhi Karpanen [Finlande] ; Katsumi Koshikawa [Finlande] ; Seppo Yla-Herttuala [Finlande] ; Takashi Takahashi [Finlande] ; Kari Alitalo [Finlande] | Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling |
| 002520 (2002) |
Jeffrey W. Walter [États-Unis] ; Paula E. North [États-Unis] ; Milton Waner [États-Unis] ; Adam Mizeracki [États-Unis] ; Francine Blei [États-Unis] ; John W. T. Walker [États-Unis] ; John F. Reinisch [États-Unis] ; Douglas A. Marchuk [États-Unis] | Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma |
| 002539 (2002) |
A. V. Evans ; D. J. Atherton | Recalcitrant ulcers in necrobiosis lipoidica diabeticorum healed by topical granulocyte‐macrophage colony‐stimulating factor |
| 002607 (2002) |
Ryan T. Mott ; Arlene Rosenberg ; Sandra Livingston ; Michael B. Morgan [États-Unis] | Melanoma associated with pseudoepitheliomatous hyperplasia: a case series and investigation into the role of epidermal growth factor receptor |
| 002618 (2002) |
Tatiana V. Petrova [États-Unis] ; Taija M Kinen [États-Unis] ; Tomi P. M Kel [États-Unis] ; Janna Saarela [États-Unis] ; Ismo Virtanen [États-Unis] ; Robert E. Ferrell [États-Unis] ; David N. Finegold [États-Unis] ; Dontscho Kerjaschki [Autriche] ; Seppo Yl Erttuala [Finlande] ; Kari Alitalo [États-Unis, Finlande] | Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox‐1 homeobox transcription factor |
| 002A24 (2001) |
Tanja Veikkola [Finlande, Australie] ; Lotta Jussila [Finlande, Australie] ; Taija Makinen [Finlande] ; Terhi Karpanen [Finlande] ; Michael Jeltsch [Finlande] ; Tatiana V. Petrova [Finlande] ; Hajime Kubo [Finlande] ; Gavin Thurston [États-Unis] ; Donald M. Mcdonald [États-Unis] ; Marc G. Achen [Australie] ; Steven A. Stacker [Australie] ; Kari Alitalo [Finlande] | Signalling via vascular endothelial growth factor receptor‐3 is sufficient for lymphangiogenesis in transgenic mice |
| 002B80 (2001) |
T. Yamamoto [Japon] ; Y. Sawada [Japon] ; I. Katayama [Japon] ; K. Nishioka [Japon] | Local expression and systemic release of stem cell factor in systemic sclerosis with diffuse hyperpigmentation |
| 002C08 (2001) |
T. Kawakami [Japon] ; Y. Soma [Japon] ; M. Mizoguchi [Japon] ; R. Saito [Japon] | Immunohistochemical analysis of transforming growth factor‐β3 expression in acquired reactive perforating collagenosis |
| 002C73 (2001) |
M. Kubo [Japon] ; H. Ihn [Japon] ; K. Yamane [Japon] ; Y. Asano [Japon] ; M. Jinnin [Japon] ; K. Tamaki [Japon] | Differential expression of transforming growth factor‐β receptors in squamous cell carcinoma |
| 003006 (2000) |
Y. Amo ; M. Masuzawa ; Y. Hamada ; H. Takasu ; T. Fujimura ; K. Katsuoka ; H. Tamauchi [Japon] | Serum levels of vascular endothelial growth factor in a haemangiosarcoma patient with a newly typed p53 gene point mutation |
| 003107 (2000) |
Jianming Fang ; Susan L. Dagenais ; Robert P. Erickson ; Martin F. Arlt ; Michael W. Glynn ; Jerome L. Gorski ; Laurie H. Seaver [États-Unis] ; Thomas W. Glover [États-Unis] | Mutations in FOXC2 ( MFH-1 ), a Forkhead Family Transcription Factor, Are Responsible for the Hereditary Lymphedema-Distichiasis Syndrome |
